- Westborough MA, US Robert C. Gadwood - Portage MI, US Neil J. Hayward - Westborough MA, US Michael J. Melnick - Portage MI, US Manuel A. Navia - Cambridge MA, US Toni J. Poel - Plainwell MI, US Frans L. Stassen - Cambridge MA, US Catherine A. Stewart - Wayland MI, US
- Westborough MA, US Yuelian Xu - East Haven CT, US Frans L. Stassen - Cambridge MA, US Neil J. Hayward - Westborough MA, US
International Classification:
C07D 401/06 C07D 401/14
Abstract:
The present invention provides compounds that inhibit Factor XIa or kallikrein and pharmaceutically acceptable salts thereof and compositions thereof. The present invention also provides methods of using these compounds and compositions.
- Westborough MA, US Robert C. Gadwood - Portage MI, US Neil J. Hayward - Westborough MA, US Michael J. Melnick - Portage MI, US Manuel A. Navia - Cambridge MA, US Toni J. Poel - Plainwell MI, US Frans L. Stassen - Cambridge MA, US Catherine A. Stewart - Wayland MI, US
International Classification:
C07D 205/08 C07D 417/06 C07D 401/06 C07D 405/14
Abstract:
The present invention provides compounds and compositions that inhibit Factor XIa or kallikrein and methods of using these compounds and composition.
- Westborough MA, US Robert C. Gadwood - Portage MI, US Neil J. Hayward - Hudson MA, US Michael J. Melnick - Portage MI, US Manuel A. Navia - Boston MA, US Toni J. Poel - Plainwell MI, US Frans L. Stassen - Cambridge MA, US Catherine A. Stewart - Wayland MI, US
International Classification:
C07D 205/08 C07D 405/14 C07D 417/06 C07D 401/06
Abstract:
The present invention provides compounds and compositions that inhibit Factor XIa or kallikrein and methods of using these compounds and composition.
- Westborough MA, US Robert C. Gadwood - Portage MI, US Neil J. Hayward - Hudson MA, US Michael J. Melnick - Portage MI, US Manuel A. Navia - Boston MA, US Toni J. Poel - Plainwell MI, US Frans L. Stassen - Cambridge MA, US Catherine A. Stewart - Wayland MI, US
Assignee:
EXITHERA PHARMACEUTICALS INC. - Westborough MA
International Classification:
C07D 417/06 C07D 405/14 C07D 401/06
Abstract:
The present invention provides compounds and compositions that inhibit Factor XIa or kallikrein and methods of using these compounds and composition.